Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 51, Issue 11, 2006, Pages 919-929

  Cole, Laurence A ^a,b   Khanlian, Sarah A ^a   Riley, Jaime M ^a   Butler, Stephen A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Choriocarcinoma; Germ cell neoplasms; Gestational trophoblastic neoplasms; Human chorionic gonadotropin; Testicular cancer

Indexed keywords

CHORIONIC GONADOTROPIN; HYPERGLYCOSYLATED HUMAN CHORIONIC GONADOTROPIN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; CELL DIFFERENTIATION; CELL INVASION; CHORIOCARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTROPHOBLAST; FEMALE; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; TESTIS CANCER;

ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CHORIOCARCINOMA; CHORIONIC GONADOTROPIN; EMBRYO IMPLANTATION; FEMALE; GERMINOMA; HUMANS; MALE; MICE; MODELS, ANIMAL; PREGNANCY; TESTICULAR NEOPLASMS; UTERINE NEOPLASMS;

EID: 33751217743     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (72)

1. Cole LA: Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin Chem 1997;43:2233-2243
2. Cole LA, Kardana A, Andrade-Gordon P, et al: The heterogeneity of hCG: III. The occurrence, biological and immunological activities of nicked hCG. Endocrinology 1991;129:1559-1567
3. Cole LA, Hussa RO: The carbohydrate on human chorionic gonadotropin produced by cancer cells. Adv Exp Med Biol 1984;176:245-270
4. Cole LA: O-glycosylation of proteins in the normal and neoplastic trophoblast. Troph Res 1987;2:139-148
5. Cole LA: The O-linked oligosaccharides are strikingly different on pregnancy and choriocarcinoma hCG. J Clin Endocrinol Metab 1987;65:811-813
6. Amano J, Nishimura R, Mochizuki M, et al: Comparative study of the mucin-type sugar chains of human chorionic gonadotropin present in the urine of patients with trophoblastic diseases and healthy pregnant women. J Biol Chem 1988;263:1157-1165
7. Elliott MM, Kardana A, Lustbader JW, et al: Carbohydrate and peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine 1997;7:15-32
8. Takamatsu S, Oguri S, Toba Minowa M, et al: Unusally high expression of N-acetylglucosaminyltransferase-IVa in human choriocarcinoma cell lines: A possible enzymatic basis of the formation of abnormal biantennary sugar chain. Cancer Res 1999;59:3949-3953
9. Kobata A, Takeuchi M: Structure, pathology and function of the N-linked sugar chains of human chorionic gonadotropin. Biochim Biophys Acta 1999;1455:315-326
10. Peters BP, Krzesicki RF, Hartle RJ, et al: A kinetic comparison of the processing and secretion of the alpha beta dimer and the uncombined alpha and beta subunits of chorionic gonadotropin synthesized by human choriocarcinoma cells. J Biol Chem 1984;259:15123-15130
11. Hussa RO: Immunologic and physical characterization of human chorionic gonadotropin and its subunits in cultures of human malignant trophoblast. J Clin Endocrinol Metab 1977;44:1154-1162
12. Mann K, Karl HJ: Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer. Cancer 1983;52:654-660
13. Imamura S, Armstrong GA, Birken S, et al: Detection of desialylated forms of human chorionic gonadotropin. Clin Chim Acta 1987;163:339-349
14. Cole LA, Shahabi S, Oz UA, et al: Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening. Clin Chem 1999;45:2109-2119
15. Cole LA, Khanlian SA, Sutton JM, et al: Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin Biochem 2003;36:647-655
16. Birken S, Krichevsky A, O'Connor J, et al: Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: Generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG. Endocrine 1999;10:137-144
17. O'Connor JF, Ellish N, Kakuma T, et al: Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn 1998;18:1232-1240
18. Kovalesvskaya G, Birken S, Kakuma T, et al: Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: Preliminary characterization of the hyperglycosylated hCG isotope. J Endocrinol 2002;172:497-506
19. Kovalevskaya G, Birken S, Kakuma T, et al: Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by immunometric assay for choriocarcinoma-like hCG. J Endocrinol 1999;161:99-106
20. Kovalevskaya G, Genbacev O, Fisher SJ, et al: Trophoblast origin of hCG isoforms: Cytotrophoblasts are the primary source or choriocarcinoma-like hCG. Mol Cell Endocrinol 2002;94:147-155
21. Butler SA, Khanlian SA, Cole LA: Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. Clin Chem 2001;47:2131-2106
22. Cole LA, Khanlian SA, Sutton JM, et al: Accuracy of home pregnancy tests at the time of missed menses. Am J Obstet Gynecol 2004;190:100-105
23. Cole LA: O-glycosylation of proteins in the normal and neoplastic trophoblast. Troph Res 1989;2:1479-1487
24. Lei ZM, Taylor DD, Gercel-Taylor C, et al: Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAR cells. Troph Res 1999;13:147-159
25. Hamade AL, Nakabayashi K, Sato A, et al: Transfection of antisense chorionic gonadotropin β gene into choriocarcinoma suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab 2005;90:4873-4879
26. Cole LA, Dai D, Leslie KK, et al: Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG-regulated neoplasia. Gynecol Oncol 2006;102:145-150
27. Cole LA, Butler SA, Khanlian SA, et al: Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol 2006;102:151-159
28. Kliman HJ, Nestler JE, Sermasi E, et al: Purification, characterization, and in vivo differentiation of cytotrophoblasts from human term placentae. Endocrinology 1986;118:1567-1582
29. Butler SA, Ikram MS, Mathieu S, et al: The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotropin is a result of an antiapoptosis effect and not cell proliferation. Br J Cancer 2000;82:1553-1556
30. Twentyman PR, Luscome M: A study of some variables in a tetrazolium dye (MTT) based assay for cell growth. Br J Cancer 1986;56:279-285
31. Genbacev O, DiFederico E, McMaster M, et al: Invasive cytotrophoblast apoptosis in pre-eclampsia. Hum Reprod 1999;2:59-66
32. Tarrade A, Goffin F, Munaut C, et al: Effect of matrigel on human extravillous trophoblasts differentiation: Modulation of protease pattern gene expression. Biol Reprod 2002;67:1628-1637
33. Cole LA, Khanlian SA: Inappropriate management of women with persistent low hCG results. J Reprod Med 2004;49:423-432
34. Khanlian SA, Smith HO, Cole LA: Persistent low levels of hCG: A pre-malignant gestational trophoblastic disease. Am J Obstet Gynecol 2003;188:1254-1259
35. Paradinas FJ, Sbire NJ, Rees HC: Pathology. In Gestational Trophoblastic Disease. Edited by BW Hancock, ES Newlands, RS Berkowitz, et al. Sheffield, UK, Sheffield University, 2003, pp 77-129
36. Ulbright TM: Germ cell neoplasms of the testis. Am J Surg Pathol 1993;17:1075-1091
37. Morinaga S, Haga N, Sasano N: Ultrastructural localization of hCG in the placenta and in testicular germ cell tumors. Virchows Arch [B Cell Pathol] 1984;45:397-406
38. Lapthorn AJ, Harris DC, Littlejohn A, et al: Crystal structure of hCG. Nature 1994;369:455-461
39. Wu H, Lustbader JW, Liu Y, et al: Structure of hCG at 2.6A resolution from MAD analysis and selenomethionyl protein. Structure 1994;2:545-548
40. Lala PK, Graham CH: Mechanisms of trophoblast invasiveness and their control: The role of proteases and protease inhibitors. Cancer Metast Rev 1990;9:369-379
41. Strickland S, Richards WG: Invasion of the trophoblasts. Cell 1992;71:355-357
42. Lash GE, Cartwright JE, Whitley GS, et al: The effects of angiogenic growth factors on extravillous trophoblast invasion and motility. Placenta 1999;20:661-667
43. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, et al: Inhibition of TGF-B3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest 1999;103:1641-1650
44. Khoo NK, Bechberger JF, Shepherd T, et al: SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype: I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFβ. Int J Cancer 1998;77:429-439
45. Graham CH, Lysiak JJ, McCrae KR, et al: Localisation of transforming growth factor-beta at the human fetal-maternal interface: Role in trophoblast growth and differentiation. Biol Reprod 1992;46:561-572
46. Lala PK, Hamilton GS: Growth factors proteases and protease inhibitors in the maternal-fetal dialogue. Placenta 1996;17:545-555
47. Mitchell EJ, Lee K, O'Conner-McCourt MD: Characterization TGF-β receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein. Mol Biol Cell 1992;3:1295-1307
48. Chen J, Laughlin LS, Hendrickx AG, et al: The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on chorionic gonadotrophin activity in pregnant macaques. Toxicology 2003;186:21-31
49. Makrigiannakis A, Zoumakis E, Kalantaridou S, et al: Corticotropin- releasing hormone (CRH) and immunotolerance of the fetus. Biochem Pharmacol 2003;65:917-921
50. Aschkenazi S, Straszewski S, Verwer KM, et al: Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod 2002;66:1853-1861
51. Leach RE, Romero R, Kim YM, et al: Pre-eclampsia and expression of heparin-binding EGF-like growth factor. Lancet 2002;360:1215-1219
52. Kauma S, Matt D, Strom S, et al: Interleukin-1, human leukocyte antigen HLA-DR and transforming growth factor-β expression in endometrium, placenta and placental membranes. Am J Obstet Gynecol 1990;163:1430-1437
53. Kayisli UA, Mahutte NG, Arici A: Uterine chemokines in reproductive physiology and pathology. Am J Reprod Immunol 2002;47:213-221
54. Hung TH, Skepper JN, Burton GJ: Hypoxia-reoxygenation: A potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circulation Res 2002;90:1274-1281
55. Zhou Y, McMaster M, Woo K, et al: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002;160:1405-1423
56. Emmer PM, Steegers EA, Kerstens HM, et al: Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Hum Reprod 2002;17:1072-1080
57. Selam B, Kayisli UA, Mulayim N, et al: Regulation of Fas ligand expression by estradiol and progesterone in human endometrium. Biol Reprod 2001;65:979-985
58. Mor G, Gutierrez LS, Eliza M, et al: Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease. Am J Reprod Immunol 1998;40:89-94
59. Robson SH, Bulmer SC, Barber A, et al: Transforming growth factor-β expression in human placenta and placental bed during early pregnancy. Placenta 2002;23:44-58
60. Lysiak JJ, Hunt J, Pringle GA, et al: Localization of TGFβ and its natural inhibitor decorin in the human placenta and deciduas throughout gestation. Placenta 1995;16:221-231
61. Selick CE, Horowitz GM, Gratch M, et al: Immunohistochemical localization of transforming growth factor-beta in human implantation sites. J Clin Endocrinol Metab 1994;78:592-596
62. Vuckovic M, Genbacev O, Kumar S: Immunohistochemical localisation of transforming growth factor-beta in first and third trimester human placenta. Pathobiology 1992;60:149-151
63. Fei G, Peng W, Xin-Lei C, et al: Apoptosis occurs in implantation site of the rhesus monkey during early stage of pregnancy. Contraception 2001;64:193-200
64. Xu G, Chakraborty C, Lala PK: Restoration of TGF-β regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells. Biochem Biophys Res Comm 2002;294:1079-1086
65. Graham CH, Connelly I, MacDougall JR, et al: Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-β. Exp Cell Res 1994;214:93-99
66. Neale D, Demasio K, Illuzi J, et al: Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: Evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonat Med 2003;13:39-44
67. Aschkenazi S, Straszewski S, Verwer KM, et al: Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells. Biol Reprod 2002;66:1853-1861
68. Kamsteeg M, Rutherford T, Sapi E, et al: Phenoxodiol-an isoflavone analog-induces apoptosis in chemoresistant ovarian cancer cells. Oncogene 2003;22:2611-2620
69. Neale D, lluzi J, Romero R, et al: Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: Evidence for an increased sensitivity to Fas-mediated apoptosis. J Matern Fetal Neonat Med 2001;13:39-44
70. Mor G, Straszewski S, Kamsteeg M: Role of the Fas/Fas ligand system in female reproductive organs: Survival and apoptosis. Biochem Pharmacol 2002;64:1305-1315
71. Song J, Rutherford T, Naftolin F, et al: Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells: Mole. Hum Reprod 2002;8:447-455
72. Butler SA, Cole LA, Chard T, et al: Dissociation of hCG into its free subunits is dependent on naturally occurring molecular structural variation, sample matrix and storage conditions. Ann Clin Biochem 1998;35:754-760